Stock screener
All disclosures →
EDGAR →
MRNA
Conviction 86HealthcareScan · Thu, Sep 24, 2026Moderna, Inc. (MRNA) closed at $194.92 (+7.03%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 75, RS Rating 99, at a 52-week high, +531.6% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).
MRNA$194.92+7.03%
ResistanceSupportVol 14Insider sellCongress buyCongress sell4
Vol MA14 14.96M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
WSB mentions · 24h changelatest +900.00%· 20 mentions
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price194.92
Change+7.03%
Gap-0.76%
Rel volume1.31×
Avg volume16.73M
Avg $ vol2.6B
SMA 20152.89
SMA 50107.40
SMA 20063.40
Price vs 50+81.49%
Price vs 200+207.44%
MA stackbullish
50/200 cross—
Supertrendup · 148.18
RSI (14)75
MACD hist2.30
MACD crossbull · 2d
Stoch %K / %D99 / 91
ADX (14)59
+DI / −DI43 / 6
RSI divergence—
MACD divergence—
ATR %6.68%
ADR %7.03%
52w high194.92
52w low22.36
From 52w high+0.00%
Above 52w low+771.74%
New 52w highYes
SqueezeOff
Bollinger width43.24%
%B1.14
Donchian pos98.91%
Donchian high195.63
Donchian low130.38
AVWAP (52w high)190.43
vs AVWAP high+2.36%
AVWAP (52w low)82.74
vs AVWAP low+135.59%
OBV trendFlat
Chaikin MF (20)0.22
Today vs 20d1.31×
Avg vol (14d)14.96M
Avg vol (20d)16.73M
Avg $ vol (20d)2.6B
Market cap77.82B
RS Rating99 / 99
RS 3m (vs SPY)+221.73%
RS 6m (vs SPY)+247.25%
RS line new highYes
Trend template8/8
Technical rank99.3
1 week+23.31%
1 month+22.72%
3 months+226.23%
6 months+264.06%
1 year+655.80%
YTD+531.63%
P/E-27.58
P/B11.51
P/S40.03
P/FCF-37.68
EPS-7.26
Div yield—
ROE-41.74%
ROA-25.75%
Debt/Eq0.09
Current2.29
EV/EBITDA-26.79
Gross margin—
Net margin-145.16%
Rev growth-39.93%
EPS growth20.75%
Price target107.29
Target upside-44.96%
Analyst ratingHold
Institutional92.32%
Ent. value76.69B
Revenue145M
Net income-782M
Gross profit—
Free cash flow-2.06B
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out396.79M
Employees4.7K
ListedFri, Dec 7, 2018
Free float361.08M
Float %91.0%
Short interest39.15M
Days to cover0.8d
Short volume64.8%
Squeeze score47 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.97 vs −$1.97
Last surprise0.0% beat
Setup gradeA
Conviction86 / 100
Pattern quality—
Tech rank99.3 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance169.02
Support53.19
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- MRNA Hits 52-Week High: How Melanoma Study Results Keep Rally GoingYahoo Finance · Tue, Sep 22, 2026
- Moderna Stock Jumped 12% Yesterday. An ESMO Presidential Slot Explains Why.Tikr · Tue, Sep 22, 2026
- Why Did AMD, WBD, MRNA Stocks Surge To 52-Week Highs Today?Stocktwits · Tue, Sep 22, 2026
- Moderna (MRNA) Stock Trades Up, Here Is WhyYahoo Finance · Tue, Sep 22, 2026
- Stocks in Demand: MRNA and SAMAIDEN Lead Investor AttentionsMoomoo · Mon, Sep 21, 2026
- MRNA Looks 618.5% Overvalued on GF Value™ as Price-to-Sales Soars Amid Oncology DataGuruFocus · Mon, Sep 21, 2026
- MRNA Looks 618.5% Overvalued on GF Value™ Amid Price-to-Sales DisconnectGuruFocus · Mon, Sep 21, 2026
- Stocks to watch on Monday after hours: MRNA, ARM, and PBFSeeking Alpha · Mon, Sep 21, 2026
- AMD, Intel, Meta, Warner Bros., Moderna, Grail, Strategy, and More Stocks That Explain Today’s MarketYahoo Finance · Mon, Sep 21, 2026
- Moderna rallies 12% to set new high (MRNA:NASDAQ)Seeking Alpha · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in MRNA · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Maria Elvira Salazar house · R · FL · traded 2026-08-19 | Sell | $1K–$15K | 2026-08-19 | 2026-09-09 | |
 Rob Bresnahan house · PA · traded 2025-04-08 | Sell | $1K–$15K | 2025-04-08 | 2025-05-08 | |
Rob Bresnahan house · PA · traded 2025-02-25 | Buy | $1K–$15K | 2025-02-25 | 2025-03-27 | |
 Julie Johnson house · D · TX · traded 2025-01-15 | Sell | $1K–$15K | 2025-01-15 | 2025-02-12 |
Insider activity
SEC Form 4 transactions in MRNA
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Restricted Stock Units · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Restricted Stock Units · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Tax | 296 | $42K | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-28 | Exercise | 611 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Common Stock · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Common Stock · 2026-08-28 | Tax | 160 | $23K | 2026-08-28 | 2026-08-31 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Mock James M Chief Financial Officer · Restricted Stock Units · 2026-08-28 | Exercise | 329 | — | 2026-08-28 | 2026-08-31 |
Hoge Stephen President · Common Stock · 2026-08-27 | Exercise | 1.44K | — | 2026-08-27 | 2026-08-31 |
SEC filings
EDGAR filings in MRNA · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.